Cargando…

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

BACKGROUND: While BRCA mutation carriers possess a 20-40% lifetime risk of developing ovarian cancer, knowledge about genetic modifying factors influencing the phenotypic expression remains obscure. We explored the distribution of the MDM2 polymorphisms SNP309T>G and the recently discovered SNP28...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjørnslett, Merete, Knappskog, Stian, Lønning, Per Eystein, Dørum, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519699/ https://www.ncbi.nlm.nih.gov/pubmed/23039163 http://dx.doi.org/10.1186/1471-2407-12-454

Ejemplares similares

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
por: Knappskog, Stian, et al.
Publicado: (2011)

The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer
por: Gansmo, Liv B., et al.
Publicado: (2016)

MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
por: Knappskog, Stian, et al.
Publicado: (2012)

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients
por: Deben, Christophe, et al.
Publicado: (2017)

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
por: Gansmo, Liv B., et al.
Publicado: (2017)

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
por: Copson, Ellen R, et al.
Publicado: (2006)

MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk
por: Gansmo, Liv B., et al.
Publicado: (2015)

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)
por: Knappskog, Stian, et al.
Publicado: (2014)

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer
por: Gansmo, Liv B., et al.
Publicado: (2021)

MDM2 SNP309 polymorphism is associated with colorectal cancer risk
por: Wang, Weizhi, et al.
Publicado: (2014)

Rapid Detection of SNP (c.309T>G) in the MDM2 Gene by the Duplex SmartAmp Method
por: Enokida, Yasuaki, et al.
Publicado: (2013)

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
por: Lønning, Per Eystein, et al.
Publicado: (2018)

Correlations between MDM2 gene SNP309 Polymorphism and Susceptibility to Leukemia
por: Ou, Wen-Bin
Publicado: (2015)

Prognostic Impact of the MDM2(SNP309) Allele in Leukemia and Lymphoma
por: Post, Sean M., et al.
Publicado: (2010)

Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study
por: Miedl, Heidi, et al.
Publicado: (2019)

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis
por: Wang, Ping, et al.
Publicado: (2016)

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer
por: Helwa, Reham, et al.
Publicado: (2016)

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
por: Olsson, Hans, et al.
Publicado: (2013)

An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk
por: Qin, Xue, et al.
Publicado: (2013)

MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis
por: Ma, Yong, et al.
Publicado: (2013)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015)

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
por: Stoehr, C G, et al.
Publicado: (2016)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
por: Wan, Yan, et al.
Publicado: (2011)

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
por: Xie, Linguo, et al.
Publicado: (2015)

MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians
por: Bittenbring, Joerg, et al.
Publicado: (2008)

A case‐control study on the SNP309T → G and 40‐bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer
por: Jalilvand, Amin, et al.
Publicado: (2020)

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics
por: Stoehr, R, et al.
Publicado: (2008)

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2013)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
por: YONEDA, TOMOKO, et al.
Publicado: (2013)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

AB265. Association between MDM2 SNP309T>G polymorphism and the risk of bladder cancer: new data in Chinese population and an update meta-analysis
por: Xie, Linguo, et al.
Publicado: (2016)

A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population
por: Reza, Hasan Al, et al.
Publicado: (2020)

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN
por: HE, WENWU, et al.
Publicado: (2012)

Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis
por: Zou, Xinwei, et al.
Publicado: (2018)

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
por: Paulin, Fiona EM, et al.
Publicado: (2008)

Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene
por: Mittelstrass, Kirstin, et al.
Publicado: (2008)

Association of MDM2 SNP309 Variation with Lung Cancer Risk: Evidence from 7196 Cases and 8456 Controls
por: Zhuo, Wenlei, et al.
Publicado: (2012)

Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population
por: Tantengco, Ourlad Alzeus G, et al.
Publicado: (2019)

Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lpjjkoeitm4nlvio6ge3taklik